Tapewire

Nasdaq · USD

PTCT

PTC THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
3803
SEC CIK
0001070081
Parsed reports
477

Last 12 months

Inside the activity.

0 purchase rows · 202 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025039
Dec 2025021
Jan 2026042
Feb 2026014
Mar 202606
Apr 202607
May 2026010
Jun 2026018
Jul 2026020
Aug 2026012
Sep 202608
Oct 202605

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 08, 2025 Filed Jan 10, 2025 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 1,552 $44.50 $69,064.00
Disclosure

SEC source: 0001415889-25-001290 · form4-01102025_050101.xml · nonDerivative · entry 3

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 103,231

F3 · shares: Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs and the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
SaleCommon Stock 1,291 $45.34 $58,533.94
Disclosure

SEC source: 0001415889-25-001295 · form4-01102025_050111.xml · nonDerivative · entry 1

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,983

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 3,500 RSUs from a January 5, 2023 grant of 14,000 RSUs.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 22:20 UTC
Pauwels EricCHIEF EXECUTIVE OFFICER
SaleCommon Stock 1,599 $45.34 $72,498.66
Disclosure

SEC source: 0001415889-25-001294 · form4-01102025_050109.xml · nonDerivative · entry 1

Pauwels Eric · CIK 0001323212 · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,941

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,500 RSUs from a January 5, 2023 grant of 18,000 RSUs.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 22:20 UTC
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 2,142 $45.34 $97,118.28
Disclosure

SEC source: 0001415889-25-001293 · form4-01102025_050107.xml · nonDerivative · entry 1

Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 286,232

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from a January 5, 2023 grant of 26,000 RSUs.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 22:20 UTC
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
SaleCommon Stock 810 $45.34 $36,725.40
Disclosure

SEC source: 0001415889-25-001292 · form4-01102025_050105.xml · nonDerivative · entry 1

Golden Lee Scott · CIK 0001686217 · EVP & CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,849

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,666 RSUs from a January 5, 2023 grant of 10,640 RSUs.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 1,543 $45.34 $69,959.62
Disclosure

SEC source: 0001415889-25-001291 · form4-01102025_050103.xml · nonDerivative · entry 1

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,846

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 55 $45.34 $2,493.70
Disclosure

SEC source: 0001415889-25-001290 · form4-01102025_050101.xml · nonDerivative · entry 2

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 6,082

F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 177 RSUs from a January 5, 2023 grant of 710 RSUs.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 1,265 $45.34 $57,355.10
Disclosure

SEC source: 0001415889-25-001290 · form4-01102025_050101.xml · nonDerivative · entry 1

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 104,783

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantStock Option (Right to Buy) · Derivative 8,800 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001029 · form4-01072025_050130.xml · derivative · entry 2

Young Alethia · CIK 0001918147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,800

Underlying: Common Stock · 8,800 shares

Expires 2035-01-02

F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001029 · form4-01072025_050130.xml · nonDerivative · entry 1

Young Alethia · CIK 0001918147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,067

F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantStock Option (Right to Buy) · Derivative 8,800 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001030 · form4-01072025_050132.xml · derivative · entry 2

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,800

Underlying: Common Stock · 8,800 shares

Expires 2035-01-02

F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001030 · form4-01072025_050132.xml · nonDerivative · entry 1

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,500

F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantStock Option (Right to Buy) · Derivative 8,800 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001028 · form4-01072025_050128.xml · derivative · entry 2

STEELE GLENN JR MD PHD · CIK 0001269131 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,800

Underlying: Common Stock · 8,800 shares

Expires 2035-01-02

F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001028 · form4-01072025_050128.xml · nonDerivative · entry 1

STEELE GLENN JR MD PHD · CIK 0001269131 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,500

F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantStock Option (Right to Buy) · Derivative 8,800 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001027 · form4-01072025_050126.xml · derivative · entry 3

SOUTHWELL DAVID P · CIK 0001251553 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,800

Underlying: Common Stock · 8,800 shares

Expires 2035-01-02

F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001027 · form4-01072025_050126.xml · nonDerivative · entry 1

SOUTHWELL DAVID P · CIK 0001251553 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,850

F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantStock Option (Right to Buy) · Derivative 8,800 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001026 · form4-01072025_050124.xml · derivative · entry 2

Smith Mary L. · CIK 0001866044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,800

Underlying: Common Stock · 8,800 shares

Expires 2035-01-02

F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001026 · form4-01072025_050124.xml · nonDerivative · entry 1

Smith Mary L. · CIK 0001866044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,813

F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Reeve EmmaDirector
GrantStock Option (Right to Buy) · Derivative 8,800 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001025 · form4-01072025_050122.xml · derivative · entry 2

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,800

Underlying: Common Stock · 8,800 shares

Expires 2034-02-15

F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Reeve EmmaDirector
GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001025 · form4-01072025_050122.xml · nonDerivative · entry 1

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,200

F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantStock Option (Right to Buy) · Derivative 8,800 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001024 · form4-01072025_050120.xml · derivative · entry 2

Okey Stephanie · CIK 0001742616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,800

Underlying: Common Stock · 8,800 shares

Expires 2035-01-02

F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001024 · form4-01072025_050120.xml · nonDerivative · entry 1

Okey Stephanie · CIK 0001742616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,867

F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantStock Option (Right to Buy) · Derivative 8,800 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001023 · form4-01072025_050118.xml · derivative · entry 2

Jacobson Allan Steven · CIK 0001579003 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,800

Underlying: Common Stock · 8,800 shares

Expires 2035-01-02

F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001023 · form4-01072025_050118.xml · nonDerivative · entry 1

Jacobson Allan Steven · CIK 0001579003 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,348

F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantStock Option (Right to Buy) · Derivative 17,600 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001022 · form4-01072025_050115.xml · derivative · entry 2

SCHMERTZLER MICHAEL · CIK 0001288952 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,600

Underlying: Common Stock · 17,600 shares

Expires 2035-01-02

F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC GrantCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001022 · form4-01072025_050115.xml · nonDerivative · entry 1

SCHMERTZLER MICHAEL · CIK 0001288952 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,266

F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
GrantStock Option (Right to Buy) · Derivative 35,000 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001021 · form4-01072025_050113.xml · derivative · entry 2

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2025-01-02

F3 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
GrantCommon Stock 14,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001021 · form4-01072025_050113.xml · nonDerivative · entry 1

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,274

F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026.

F2 · balance_after: Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001020 · form4-01072025_050111.xml · derivative · entry 2

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2035-01-02

F2 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
GrantCommon Stock 18,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001020 · form4-01072025_050111.xml · nonDerivative · entry 1

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,389

F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
GrantStock Option (Right to Buy) · Derivative 47,500 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001019 · form4-01072025_050109.xml · derivative · entry 3

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,500

Underlying: Common Stock · 47,500 shares

Expires 2035-01-02

F3 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
GrantCommon Stock 715 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001019 · form4-01072025_050109.xml · nonDerivative · entry 2

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 6,137

F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026.

F2 · balance_after: Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
GrantCommon Stock 19,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001019 · form4-01072025_050109.xml · nonDerivative · entry 1

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,048

F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026.

F2 · balance_after: Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001018 · form4-01072025_050107.xml · derivative · entry 2

Golden Lee Scott · CIK 0001686217 · EVP & CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-01-02

F3 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001018 · form4-01072025_050107.xml · nonDerivative · entry 1

Golden Lee Scott · CIK 0001686217 · EVP & CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,659

F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026.

F2 · balance_after: Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Pauwels EricCHIEF EXECUTIVE OFFICER
GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001017 · form4-01072025_050105.xml · derivative · entry 2

Pauwels Eric · CIK 0001323212 · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2035-01-02

F3 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Pauwels EricCHIEF EXECUTIVE OFFICER
GrantCommon Stock 22,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001017 · form4-01072025_050105.xml · nonDerivative · entry 1

Pauwels Eric · CIK 0001323212 · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,540

F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026.

F2 · balance_after: Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Gravier PierreCHIEF FINANCIAL OFFICER
GrantStock Option (Right to Buy) · Derivative 56,250 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001016 · form4-01072025_050103.xml · derivative · entry 2

Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,250

Underlying: Common Stock · 56,250 shares

Expires 2035-01-02

F3 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Gravier PierreCHIEF FINANCIAL OFFICER
GrantCommon Stock 22,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001016 · form4-01072025_050103.xml · nonDerivative · entry 1

Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,771

F1 · price: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026.

F2 · balance_after: Includes 339 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
GrantStock Option (Right to Buy) · Derivative 175,000 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001415889-25-001015 · form4-01072025_050101.xml · derivative · entry 2

Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2035-01-02

F3 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:20 UTC
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
GrantCommon Stock 70,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001015 · form4-01072025_050101.xml · nonDerivative · entry 1

Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 288,374

F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026.

F2 · balance_after: Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024.

Read SEC document
December 31, 2024 Filed Jan 3, 2025 22:21 UTC
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 8,279 $45.16 $373,879.64
Disclosure

SEC source: 0001415889-25-000580 · form4-01032025_100132.xml · nonDerivative · entry 1

Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 217,528

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 18,750 RSUs from a December 28, 2023 grant of 75,000 RSUs.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionStock Option (Right to Buy) · Derivative 1,988 $0.00 Strike: $33.02 $0.00
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · derivative · entry 17

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,512

Underlying: Common Stock · 1,988 shares

Expires 2029-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

F8 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionStock Option (Right to Buy) · Derivative 7,720 $0.00 Strike: $33.02 $0.00
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · derivative · entry 16

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,110

Underlying: Common Stock · 7,720 shares

Expires 2029-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

F8 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionStock Option (Right to Buy) · Derivative 600 $0.00 Strike: $33.02 $0.00
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · derivative · entry 15

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,070

Underlying: Common Stock · 600 shares

Expires 2029-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

F8 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 88 $54.14 $4,764.32
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 12

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,389

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 1,900 $53.13 $100,947.00
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 11

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,477

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

F7 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to $53.62 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionCommon Stock 1,988 $33.02 $65,643.76
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 10

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,377

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 1,405 $54.05 $75,940.25
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 9

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,389

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

F6 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.025 to $54.16 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 6,315 $53.14 $335,579.10
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 8

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 93,794

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

F5 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to 53.995 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.